Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Lip augmentation Market by Type (Temporary Lip Augmentation, Permanent Lip Augmentation, Lip Lift), by Lip Fillers (Fat Injection or Lipoinjection, Hyaluronic Acid Fillers, Lip Collagen Injections, Platelet-rich Plasma (PRP), Others) and by End users (Hospital Pharmacies, Clinics, Retail Pharmacies, Drug Stores, Online Pharmacies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A10206

Pages: NA

Charts: NA

Tables: NA

Augmentations of the lips are cosmetic procedures that help in providing the fuller and plumper lips. In recent days, injectable dermal fillers are the most frequently used lip augmentation method. There are different types of dermal fillers and are injected in and around the lips and mouth. However, most of the common fillers used today are products that consist of the substances indistinguishable to the hyaluronic acid. Hyaluronic acids are substances that are naturally found in the body. This helps in increasing lips volume. Dermal fillers are also called hyaluronic acid fillers.

Amongst all the dermal fillers collagen are the most highly used and common dermal filler. Having said that, due to the emergence of new options which have a longer effect and are comparatively safer. Implants and fat injections are some of the other techniques used to plump the lips. Owing to the risk factors and side effects the techniques are not used today regularly.

Hyaluronic acid fillers helps in improving the lips by adding structure, shape, and volume. The effect of the augmentation remains for about six months. After the effect wears off, injectable needs to be used again for retaining the volume of your lips.

COVID-19 scenario analysis:

Coronavirus disease 2019 (COVID-19) has created an economic crisis along with a health care crisis. COVID-19 pandemic has stretched healthcare system worldwide, developed countries are expected to cause an economic recession. The Covid-19 pandemic has an adverse impact on the healthcare system, resulting in 50% to 70% drop in revenue from March. Many small hospitals, clinics, and nursing homes, have been forced to shut their operations. As a result of social distancing and localized curfews have resulted in delayed elective surgical procedures. In addition, visa cancellations have led to a hiatus in medical tourism and can negatively impact the healthcare services market growth.

Owing to such factors, COVID 19 is expected to have a significant impact on the Lip augmentation market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

There has been an increase in the demand for cosmetic surgery for the older and younger population alike; upgrades in the technology and introduction of new cosmetic surgeons are the major factors propelling the growth of the lip augmentation market.

Ballooned surgeries, selfie surgeries, and many other new options arising due to the advancements in the techniques are growing the lip augmentation market. Endorsements by the celebrities social media effects increasing and influencing are affecting the growth of the lip augmentation market.

Along with this, effects of stressful lifestyle on the skin and unhealthiness, screen time improvement, disposable income increase, affordability, awareness and acceptance of the cosmetic procedures, consumer awareness, affordability, advancements in the technology, the dissatisfaction of the teenagers and young adults in regards to the body, procedure safety are also affecting the growth of the lip augmentation market.

Moreover, awareness for the lip augmentation sectors increasing; a significant rise in the geriatric population and demand for dermal fillers increasing are boosting the growth of the market.

On the other hand, side effects related to the lip fillers and expensive treatment are expected to restrain the growth of the lip augmentation market.

New product launches and acquisitions to flourish the market:

On October 4th, 2018, Allergan plc introduced a new advertising campaign JUVÉDERM which helped them in creating awareness in the millennial generations to "JUVÉDERM IT."

On February 1st, 2017, LifeCell Corporation was acquired by Allergan plc which was a leading medicine company focused on regenerative.

Surge in usage in hospitals and patients segment applications:

Hospital Pharmacies, Retail Pharmacies, Clinics, Drug Stores, and Online Pharmacies are the major consumers of the lip augmentation market. Amongst them, hospital pharmacies are the biggest end-users sue to the demand rising for cosmetic procedures.

Key benefits of the report:

  • This study presents the analytical depiction of the global Lip augmentation industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Lip augmentation market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Lip augmentation market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Lip augmentation Market research report:

  • What are the leading market players active in the Lip augmentation market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

  • By Type
    • Temporary Lip Augmentation
    • Permanent Lip Augmentation
      • Dermal Graft
      • Permanent Lip Implants
      • Vermilion Lip Advancement
    • Lip Lift
      • Corner Lip Lift
      • Upper Lip Lift
  • By Lip Fillers
    • Fat Injection or Lipoinjection
    • Hyaluronic Acid Fillers
    • Lip Collagen Injections
    • Platelet-rich Plasma (PRP)
    • Others
  • By End users
    • Hospital Pharmacies
    • Clinics
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Laboratories Vivacy SAS
  • Allergan
  • Sinclair Pharma
  • Suneva Medical, Inc
  • Syneron
  • Merz Pharma
  • Galderma Pharma S.A.
  • Teoxane
  • Cynosure
  • Integra Lifesciences
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LIP AUGMENTATION MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Temporary Lip Augmentation

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Permanent Lip Augmentation

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Dermal Graft

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Permanent Lip Implants

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Vermilion Lip Advancement

        • 4.3.4.1. Market Size and Forecast
    • 4.4. Lip Lift

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Corner Lip Lift

        • 4.4.4.1. Market Size and Forecast
      • 4.4.4. Upper Lip Lift

        • 4.4.4.1. Market Size and Forecast
  • CHAPTER 5: LIP AUGMENTATION MARKET, BY LIP FILLERS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Lip Fillers

    • 5.2. Fat Injection Or Lipoinjection

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Hyaluronic Acid Fillers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Lip Collagen Injections

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Platelet-rich Plasma (PRP)

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: LIP AUGMENTATION MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospital Pharmacies

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Retail Pharmacies

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Drug Stores

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Online Pharmacies

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Others

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

  • CHAPTER 7: LIP AUGMENTATION MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Lip Fillers

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Lip Augmentation Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Lip Fillers
        • 7.2.6.3. Market Size and Forecast, By End Users
      • 7.2.7. Canada Lip Augmentation Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Lip Fillers
        • 7.2.7.3. Market Size and Forecast, By End Users
      • 7.2.8. Mexico Lip Augmentation Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Lip Fillers
        • 7.2.8.3. Market Size and Forecast, By End Users
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Lip Fillers

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Lip Augmentation Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Lip Fillers
        • 7.3.6.3. Market Size and Forecast, By End Users
      • 7.3.7. Germany Lip Augmentation Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Lip Fillers
        • 7.3.7.3. Market Size and Forecast, By End Users
      • 7.3.8. Italy Lip Augmentation Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Lip Fillers
        • 7.3.8.3. Market Size and Forecast, By End Users
      • 7.3.9. Spain Lip Augmentation Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Lip Fillers
        • 7.3.9.3. Market Size and Forecast, By End Users
      • 7.3.10. UK Lip Augmentation Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Lip Fillers
        • 7.3.10.3. Market Size and Forecast, By End Users
      • 7.3.11. Russia Lip Augmentation Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Lip Fillers
        • 7.3.11.3. Market Size and Forecast, By End Users
      • 7.3.12. Rest Of Europe Lip Augmentation Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Lip Fillers
        • 7.3.12.3. Market Size and Forecast, By End Users
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Lip Fillers

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Lip Augmentation Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Lip Fillers
        • 7.4.6.3. Market Size and Forecast, By End Users
      • 7.4.7. Japan Lip Augmentation Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Lip Fillers
        • 7.4.7.3. Market Size and Forecast, By End Users
      • 7.4.8. India Lip Augmentation Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Lip Fillers
        • 7.4.8.3. Market Size and Forecast, By End Users
      • 7.4.9. South Korea Lip Augmentation Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Lip Fillers
        • 7.4.9.3. Market Size and Forecast, By End Users
      • 7.4.10. Australia Lip Augmentation Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Lip Fillers
        • 7.4.10.3. Market Size and Forecast, By End Users
      • 7.4.11. Thailand Lip Augmentation Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Lip Fillers
        • 7.4.11.3. Market Size and Forecast, By End Users
      • 7.4.12. Malaysia Lip Augmentation Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Lip Fillers
        • 7.4.12.3. Market Size and Forecast, By End Users
      • 7.4.13. Indonesia Lip Augmentation Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Lip Fillers
        • 7.4.13.3. Market Size and Forecast, By End Users
      • 7.4.14. Rest of Asia Pacific Lip Augmentation Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Lip Fillers
        • 7.4.14.3. Market Size and Forecast, By End Users
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Lip Fillers

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Lip Augmentation Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Lip Fillers
        • 7.5.6.3. Market Size and Forecast, By End Users
      • 7.5.7. South Africa Lip Augmentation Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Lip Fillers
        • 7.5.7.3. Market Size and Forecast, By End Users
      • 7.5.8. Saudi Arabia Lip Augmentation Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Lip Fillers
        • 7.5.8.3. Market Size and Forecast, By End Users
      • 7.5.9. UAE Lip Augmentation Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Lip Fillers
        • 7.5.9.3. Market Size and Forecast, By End Users
      • 7.5.10. Argentina Lip Augmentation Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Lip Fillers
        • 7.5.10.3. Market Size and Forecast, By End Users
      • 7.5.11. Rest of LAMEA Lip Augmentation Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Lip Fillers
        • 7.5.11.3. Market Size and Forecast, By End Users
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Allergan

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Galderma Pharma S.A.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Integra Lifesciences

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Laboratories Vivacy SAS

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Merz Pharma

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Sinclair Pharma

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Suneva Medical, Inc

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Teoxane

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cynosure

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Syneron

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIP AUGMENTATION MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LIP AUGMENTATION MARKET FOR TEMPORARY LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LIP AUGMENTATION MARKET FOR PERMANENT LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LIP AUGMENTATION MARKET FOR LIP LIFT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LIP AUGMENTATION MARKET, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LIP AUGMENTATION MARKET FOR FAT INJECTION OR LIPOINJECTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LIP AUGMENTATION MARKET FOR HYALURONIC ACID FILLERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LIP AUGMENTATION MARKET FOR LIP COLLAGEN INJECTIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL LIP AUGMENTATION MARKET FOR PLATELET-RICH PLASMA (PRP), BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL LIP AUGMENTATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL LIP AUGMENTATION MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL LIP AUGMENTATION MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL LIP AUGMENTATION MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL LIP AUGMENTATION MARKET FOR RETAIL PHARMACIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL LIP AUGMENTATION MARKET FOR DRUG STORES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL LIP AUGMENTATION MARKET FOR ONLINE PHARMACIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL LIP AUGMENTATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL LIP AUGMENTATION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 23. U.S. LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. U.S. LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 25. U.S. LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 26. CANADA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. CANADA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 28. CANADA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 37. FRANCE LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 38. FRANCE LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. GERMANY LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 41. GERMANY LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. ITALY LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. ITALY LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 44. ITALY LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SPAIN LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 47. SPAIN LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 48. UK LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. UK LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 50. UK LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. RUSSIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 53. RUSSIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF EUROPE LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 56. REST OF EUROPE LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. ASIA-PACIFIC LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 60. ASIA-PACIFIC LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. CHINA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. CHINA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 63. CHINA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. JAPAN LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 66. JAPAN LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 67. INDIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. INDIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 69. INDIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH KOREA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 72. SOUTH KOREA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. AUSTRALIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 75. AUSTRALIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 77. THAILAND LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 78. THAILAND LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 80. MALAYSIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 81. MALAYSIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 83. INDONESIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 84. INDONESIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA LIP AUGMENTATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 90. LAMEA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 91. LAMEA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 93. BRAZIL LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 94. BRAZIL LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 96. SOUTH AFRICA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 97. SOUTH AFRICA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 99. SAUDI ARABIA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 100. SAUDI ARABIA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 101. UAE LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. UAE LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 103. UAE LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 105. ARGENTINA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 106. ARGENTINA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA LIP AUGMENTATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 108. REST OF LAMEA LIP AUGMENTATION, BY LIP FILLERS, 2025-2033 ($MILLION)
  • TABLE 109. REST OF LAMEA LIP AUGMENTATION, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 110. ALLERGAN: KEY EXECUTIVES
  • TABLE 111. ALLERGAN: COMPANY SNAPSHOT
  • TABLE 112. ALLERGAN: OPERATING SEGMENTS
  • TABLE 113. ALLERGAN: PRODUCT PORTFOLIO
  • TABLE 114. ALLERGAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. GALDERMA PHARMA S.A.: KEY EXECUTIVES
  • TABLE 116. GALDERMA PHARMA S.A.: COMPANY SNAPSHOT
  • TABLE 117. GALDERMA PHARMA S.A.: OPERATING SEGMENTS
  • TABLE 118. GALDERMA PHARMA S.A.: PRODUCT PORTFOLIO
  • TABLE 119. GALDERMA PHARMA S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. INTEGRA LIFESCIENCES: KEY EXECUTIVES
  • TABLE 121. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
  • TABLE 122. INTEGRA LIFESCIENCES: OPERATING SEGMENTS
  • TABLE 123. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
  • TABLE 124. INTEGRA LIFESCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. LABORATORIES VIVACY SAS: KEY EXECUTIVES
  • TABLE 126. LABORATORIES VIVACY SAS: COMPANY SNAPSHOT
  • TABLE 127. LABORATORIES VIVACY SAS: OPERATING SEGMENTS
  • TABLE 128. LABORATORIES VIVACY SAS: PRODUCT PORTFOLIO
  • TABLE 129. LABORATORIES VIVACY SAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. MERZ PHARMA: KEY EXECUTIVES
  • TABLE 131. MERZ PHARMA: COMPANY SNAPSHOT
  • TABLE 132. MERZ PHARMA: OPERATING SEGMENTS
  • TABLE 133. MERZ PHARMA: PRODUCT PORTFOLIO
  • TABLE 134. MERZ PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. SINCLAIR PHARMA: KEY EXECUTIVES
  • TABLE 136. SINCLAIR PHARMA: COMPANY SNAPSHOT
  • TABLE 137. SINCLAIR PHARMA: OPERATING SEGMENTS
  • TABLE 138. SINCLAIR PHARMA: PRODUCT PORTFOLIO
  • TABLE 139. SINCLAIR PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. SUNEVA MEDICAL, INC: KEY EXECUTIVES
  • TABLE 141. SUNEVA MEDICAL, INC: COMPANY SNAPSHOT
  • TABLE 142. SUNEVA MEDICAL, INC: OPERATING SEGMENTS
  • TABLE 143. SUNEVA MEDICAL, INC: PRODUCT PORTFOLIO
  • TABLE 144. SUNEVA MEDICAL, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. TEOXANE: KEY EXECUTIVES
  • TABLE 146. TEOXANE: COMPANY SNAPSHOT
  • TABLE 147. TEOXANE: OPERATING SEGMENTS
  • TABLE 148. TEOXANE: PRODUCT PORTFOLIO
  • TABLE 149. TEOXANE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. CYNOSURE: KEY EXECUTIVES
  • TABLE 151. CYNOSURE: COMPANY SNAPSHOT
  • TABLE 152. CYNOSURE: OPERATING SEGMENTS
  • TABLE 153. CYNOSURE: PRODUCT PORTFOLIO
  • TABLE 154. CYNOSURE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. SYNERON: KEY EXECUTIVES
  • TABLE 156. SYNERON: COMPANY SNAPSHOT
  • TABLE 157. SYNERON: OPERATING SEGMENTS
  • TABLE 158. SYNERON: PRODUCT PORTFOLIO
  • TABLE 159. SYNERON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIP AUGMENTATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIP AUGMENTATION MARKET
  • FIGURE 3. SEGMENTATION LIP AUGMENTATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIP AUGMENTATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIP AUGMENTATION MARKET
  • FIGURE 11. LIP AUGMENTATION MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. LIP AUGMENTATION MARKET FOR TEMPORARY LIP AUGMENTATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LIP AUGMENTATION MARKET FOR PERMANENT LIP AUGMENTATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LIP AUGMENTATION MARKET FOR LIP LIFT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. LIP AUGMENTATION MARKET SEGMENTATION, BY BY LIP FILLERS
  • FIGURE 16. LIP AUGMENTATION MARKET FOR FAT INJECTION OR LIPOINJECTION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. LIP AUGMENTATION MARKET FOR HYALURONIC ACID FILLERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. LIP AUGMENTATION MARKET FOR LIP COLLAGEN INJECTIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. LIP AUGMENTATION MARKET FOR PLATELET-RICH PLASMA (PRP), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. LIP AUGMENTATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. LIP AUGMENTATION MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 22. LIP AUGMENTATION MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. LIP AUGMENTATION MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. LIP AUGMENTATION MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. LIP AUGMENTATION MARKET FOR DRUG STORES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. LIP AUGMENTATION MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. LIP AUGMENTATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: LIP AUGMENTATION MARKET
  • FIGURE 34. TOP PLAYER POSITIONING, 2024
  • FIGURE 35. ALLERGAN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. ALLERGAN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. ALLERGAN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. GALDERMA PHARMA S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. GALDERMA PHARMA S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. GALDERMA PHARMA S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. INTEGRA LIFESCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. INTEGRA LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. INTEGRA LIFESCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. LABORATORIES VIVACY SAS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. LABORATORIES VIVACY SAS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. LABORATORIES VIVACY SAS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. MERZ PHARMA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. MERZ PHARMA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. MERZ PHARMA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. SINCLAIR PHARMA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. SINCLAIR PHARMA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. SINCLAIR PHARMA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. SUNEVA MEDICAL, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. SUNEVA MEDICAL, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. SUNEVA MEDICAL, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. TEOXANE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. TEOXANE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. TEOXANE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. CYNOSURE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. CYNOSURE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. CYNOSURE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. SYNERON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. SYNERON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. SYNERON: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Lip augmentation Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue